Many women expect hot flashes and irregular periods during menopause. What often comes as a surprise is the profound effect hormonal changes can have on mood, concentration, memory, sleep, and emotional well-being.
One of the most common statements I hear from women in my practice is, "I don't feel like myself anymore."
Some describe feeling anxious for the first time in their lives. Others notice that their ADHD medication no longer seems to work as well. Many experience increasing forgetfulness, difficulty concentrating, poor sleep, irritability, or emotional overwhelm despite having successfully managed demanding careers, families, and responsibilities for years.
These symptoms are real.
They are common.
Most importantly, they are treatable.
Perimenopause represents one of the most significant neuroendocrine transitions a woman experiences. Although much of the conversation focuses on reproductive health, the brain is one of the organs most affected by fluctuating ovarian hormones. Estrogen influences multiple neurotransmitter systems responsible for mood regulation, executive functioning, learning, memory, and sleep. As hormone levels fluctuate during the menopausal transition, these systems can become temporarily dysregulated, contributing to symptoms that are often mistaken for primary psychiatric illness, cognitive decline, or simply "getting older" (The Menopause Society, 2022; Lega et al., 2023).
Understanding why these changes occur can help women recognize that they are not imagining their symptoms—and that effective treatments are available.
Perimenopause is the transitional period before menopause, ending 12 months after a woman's final menstrual period. While the average age of menopause in the United States is approximately 51 years, perimenopause often begins during a woman's 40s and may last four to eight years, although some women experience a shorter or longer transition (The Menopause Society, 2022).
Unlike menopause, when estrogen levels remain consistently low, perimenopause is characterized by significant hormonal fluctuations. Estrogen and progesterone levels may vary dramatically over days or weeks, which explains why symptoms often seem unpredictable. One month you may sleep well and feel emotionally balanced; the next, you may struggle with insomnia, anxiety, or difficulty concentrating.
Although irregular menstrual cycles, hot flashes, and night sweats are the most recognized symptoms, many women find that the emotional and cognitive changes are even more disruptive.
Common psychological symptoms include:
These symptoms occur because estrogen affects much more than the reproductive system. Estrogen receptors are widely distributed throughout the brain, particularly in regions involved in emotional regulation, memory formation, executive functioning, and stress response (Brinton, 2024).
For decades, estrogen was viewed primarily as a reproductive hormone. We now understand that it functions as an important neuromodulator, influencing multiple neurotransmitter systems that regulate mood, cognition, and behavior.
Serotonin plays an essential role in mood regulation, anxiety, sleep, appetite, and emotional stability. Estrogen enhances serotonin synthesis, increases receptor sensitivity, and slows serotonin degradation. During perimenopause, fluctuating estrogen levels can disrupt serotonergic signaling, increasing vulnerability to anxiety and depressive symptoms (The Menopause Society, 2022).
Dopamine regulates motivation, reward, attention, working memory, and executive functioning. Estrogen enhances dopaminergic activity within the prefrontal cortex, helping support organization, planning, and sustained attention. As estrogen becomes less stable during perimenopause, many women notice worsening distractibility, forgetfulness, reduced motivation, and difficulty completing tasks—symptoms that can closely resemble ADHD or significantly worsen existing ADHD (Shanmugan & Epperson, 2021).
Estrogen also promotes production of brain-derived neurotrophic factor (BDNF), a protein essential for learning, memory, and neuroplasticity. Reduced BDNF activity has been associated with depression and cognitive dysfunction, providing another biological explanation for the "brain fog" frequently reported during the menopausal transition (Brinton, 2024).
Understanding these mechanisms is important because they reinforce an essential message: these symptoms are rooted in biology, not a lack of resilience or willpower.
Many women experience anxiety for the first time during perimenopause. Others find that previously well-controlled anxiety becomes more frequent or more intense.
Symptoms may include persistent worrying, panic attacks, racing thoughts, irritability, muscle tension, increased sensitivity to stress, or a constant sense that something is wrong.
Hormonal changes are only part of the picture. Sleep disruption, career responsibilities, caregiving for children or aging parents, and other midlife stressors often occur simultaneously, amplifying the effects of fluctuating estrogen. Research suggests that women undergoing the menopausal transition have an increased risk of clinically significant anxiety symptoms compared with premenopausal women (Lega et al., 2023).
Fortunately, anxiety during perimenopause responds well to evidence-based treatments that address both biological and psychological contributors.
The menopausal transition is also associated with an increased risk of depressive symptoms, particularly among women with a history of major depressive disorder, postpartum depression, or severe premenstrual mood symptoms (Gordon et al., 2021).
Depression during perimenopause does not always present as persistent sadness. Many women instead report emotional numbness, loss of motivation, fatigue, irritability, reduced enjoyment in activities, indecisiveness, or feeling overwhelmed by tasks that once felt manageable.
These symptoms should never be dismissed as "just hormones." While hormonal changes may contribute, depression remains a medical condition that deserves appropriate evaluation and treatment.
One of the greatest fears women express is that they may be developing dementia.
Fortunately, for most women, this is not the case.
Brain fog during perimenopause commonly includes:
These symptoms are believed to result from the combined effects of fluctuating estrogen, poor sleep, stress, mood changes, and altered neurotransmitter activity rather than progressive neurodegenerative disease (Maki & Jaff, 2022).
That said, persistent, worsening, or atypical cognitive symptoms should always be evaluated by a qualified healthcare professional to rule out other medical or neurological conditions.
One of the fastest-growing areas of women's mental health research is the relationship between estrogen and attention-deficit/hyperactivity disorder (ADHD). While estrogen does not cause ADHD, it has a meaningful influence on dopamine signaling within the prefrontal cortex—the region of the brain responsible for attention, working memory, planning, organization, and emotional regulation (Shanmugan & Epperson, 2021).
Many women with ADHD report that symptoms become significantly more noticeable during perimenopause. Tasks that once felt manageable suddenly become exhausting. Medications that were previously effective may not seem to provide the same level of symptom control throughout the menstrual cycle or during the menopausal transition. Some women, particularly those who developed strong coping strategies earlier in life, receive an ADHD diagnosis for the first time during their 40s or 50s because hormonal changes expose underlying executive functioning challenges.
Common symptoms include:
It is important to recognize that concentration problems are not always caused by ADHD. Anxiety, depression, chronic stress, sleep deprivation, thyroid disorders, nutritional deficiencies, medication side effects, and cognitive changes associated with perimenopause can all impair attention. A comprehensive psychiatric evaluation helps determine whether ADHD, hormonal changes, another medical condition, or a combination of factors is contributing to symptoms.
Sleep disruption is one of the most common—and most underestimated—symptoms of perimenopause.
Night sweats, insomnia, frequent awakenings, anxiety, restless sleep, and changes in circadian rhythm often occur together. Even women who have never struggled with sleep may find themselves waking at 3:00 a.m. unable to fall back asleep.
Unfortunately, poor sleep does much more than cause fatigue.
Research consistently demonstrates that chronic sleep disruption contributes to:
Many women assume anxiety is causing their insomnia, when in reality the relationship is bidirectional. Poor sleep increases emotional reactivity and stress sensitivity, while anxiety makes it more difficult to obtain restorative sleep. Breaking this cycle is often one of the most effective ways to improve overall mental health during perimenopause.
At Synchronous Mental Health, many women schedule an appointment believing they have developed severe anxiety, early dementia, or treatment-resistant ADHD. While these conditions certainly occur, we frequently find that hormonal fluctuations, chronic sleep disruption, and mood symptoms are interacting in ways that mimic—or worsen—other psychiatric conditions.
Rather than focusing on a single symptom, our approach is to evaluate the whole person. We consider hormonal changes, psychiatric history, medical conditions, medications, lifestyle factors, and sleep patterns to develop an individualized treatment plan. This comprehensive approach helps ensure that treatment addresses the underlying contributors rather than simply masking symptoms.
There is no single treatment that works for every woman. The most effective plan depends on symptom severity, medical history, treatment goals, and personal preferences.
Lifestyle changes should not be viewed as a replacement for medical treatment when clinically indicated, but they are an important part of comprehensive care.
Evidence supports:
Even modest improvements in physical activity and sleep quality can positively influence mood and cognitive functioning.
Psychotherapy remains an important treatment option during perimenopause.
Cognitive behavioral therapy (CBT) has demonstrated benefit for anxiety, depression, insomnia, and distress associated with vasomotor symptoms. Acceptance and Commitment Therapy (ACT), mindfulness-based therapies, and interpersonal psychotherapy may also be helpful depending on an individual's symptoms and goals (NICE, 2024).
For women experiencing moderate to severe anxiety or depression, antidepressant medications such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) may be appropriate.
Women with ADHD may benefit from stimulant or non-stimulant medications when clinically indicated. However, medication response may change during periods of hormonal fluctuation, making regular follow-up important.
Medication decisions should always consider coexisting medical conditions, potential side effects, and patient preferences.
Menopausal hormone therapy (MHT) is highly effective for treating vasomotor symptoms such as hot flashes and night sweats and may improve sleep and quality of life in appropriately selected patients (The Menopause Society, 2022).
Hormone therapy should not be prescribed solely to treat depression or anxiety. However, for women whose mood symptoms occur alongside significant vasomotor symptoms, MHT may be considered as part of a comprehensive treatment plan after discussing the potential benefits and risks with an appropriately trained clinician (The Menopause Society, 2022; ACOG, 2024).
Because perimenopause affects multiple body systems, collaboration between psychiatry, primary care, and gynecology often produces the best outcomes.
Psychiatric symptoms rarely exist in isolation. Addressing sleep, metabolic health, thyroid function, nutritional deficiencies, hormone status, and chronic medical conditions alongside mental health frequently results in more meaningful improvement than focusing on one area alone.
Although mood fluctuations can occur during perimenopause, persistent symptoms should not simply be accepted as an inevitable part of aging.
Consider scheduling an evaluation if you experience:
Seeking help early often leads to more effective treatment and can prevent symptoms from becoming more severe.
Perimenopause is a neurological as well as a reproductive transition.
Fluctuating estrogen levels influence neurotransmitters involved in mood, attention, memory, sleep, and executive functioning. As a result, many women experience anxiety, depression, brain fog, insomnia, or worsening ADHD symptoms during this stage of life.
These symptoms are common, medically recognized, and treatable.
With a comprehensive evaluation and an individualized treatment plan, most women can regain emotional stability, improve cognitive functioning, sleep better, and return to feeling more like themselves.
Yes. Anxiety commonly increases during the menopausal transition because hormonal fluctuations, sleep disruption, and psychosocial stressors often occur simultaneously (Lega et al., 2023).
Yes. Fluctuating estrogen levels may worsen executive functioning and attention, making ADHD symptoms more noticeable or reducing the effectiveness of previously successful coping strategies (Shanmugan & Epperson, 2021).
For most women, cognitive symptoms improve as hormone levels stabilize and contributing factors such as poor sleep, anxiety, or depression are treated (Maki & Jaff, 2022).
No. Menopausal hormone therapy is an excellent option for many women with bothersome vasomotor symptoms, but it is not appropriate for everyone. Treatment decisions should be individualized based on medical history, symptom severity, and shared decision-making (The Menopause Society, 2022; ACOG, 2024).
Yes. Regular exercise, adequate sleep, stress management, healthy nutrition, and limiting alcohol have all been associated with improvements in overall health and may reduce the severity of mood and cognitive symptoms during perimenopause (Lega et al., 2023).
At Synchronous Mental Health, we provide evidence-based psychiatric care for adolescents and adults experiencing ADHD, anxiety, depression, bipolar disorder, trauma-related disorders, insomnia, and women's mental health concerns, including the emotional and cognitive changes associated with perimenopause and menopause.
Our goal is to help you feel heard, understood, and supported while developing a treatment plan tailored to your unique needs. Whether your symptoms are related to hormones, ADHD, anxiety, depression, or a combination of factors, we take a comprehensive approach that considers the whole person—not just a diagnosis.
If you've noticed changes in your mood, focus, sleep, or emotional well-being during perimenopause, you don't have to navigate this transition alone.
Schedule a psychiatric evaluation with Synchronous Mental Health to learn more about evidence-based treatment options and begin feeling like yourself again.
American College of Obstetricians and Gynecologists. (2024). The menopause years. https://www.acog.org/womens-health
Gordon, J. L., Rubinow, D. R., Eisenlohr-Moul, T. A., Leserman, J., & Girdler, S. S. (2021). Characteristics of women with perimenopausal depression and considerations for treatment. Current Psychiatry Reports, 23(10), 64.
Lega, I. C., Jacobson, M. H., & colleagues. (2023). A pragmatic approach to the management of menopause. Canadian Medical Association Journal, 195(19), E677-E685.
Maki, P. M., & Jaff, N. G. (2022). Cognitive changes during the menopause transition. Obstetrics and Gynecology Clinics of North America, 49(4), 635-648.
National Institute for Health and Care Excellence. (2024). Menopause: Identification and management (NG23). https://www.nice.org.uk/guidance/ng23
Shanmugan, S., & Epperson, C. N. (2021). Estrogen and the prefrontal cortex: Towards a new understanding of women's ADHD across the lifespan. Frontiers in Neuroscience, 15, 659516.
The Menopause Society. (2022). The 2022 hormone therapy position statement of The Menopause Society. Menopause, 29(7), 767-794.
